NCT02971254View on ClinicalTrials.gov

The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

January 6, 2019

Study Completion Date

May 30, 2019

Conditions
Down Syndrome
Interventions
DRUG

Sevoflurane

DRUG

Desflurane

Trial Locations (1)

Unknown

Gkliatis Emmanouil, Athens

All Listed Sponsors
lead

Asklepieion Voulas General Hospital

OTHER_GOV

NCT02971254 - The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients | Biotech Hunter | Biotech Hunter